v3.26.1
Unaudited Condensed Consolidated Statements of Changes in Stockholders’ Equity (Deficit) - USD ($)
Common Stock
Preferred Stock (Series B, C and D)
Additional Paid-in Capital
Common Stock to be Issued
Accumulated Deficit
Total
Balance at Dec. 31, 2024 $ 2,708 $ 11,745,436 $ (10,562,799) $ 1,185,345
Balance (in Shares) at Dec. 31, 2024 27,080,915        
Share-based compensation 495,500 495,500
Issuance of shares for note payable conversions $ 143 466,026 466,169
Issuance of shares for note payable conversions (in Shares) 1,429,717          
Issuance of equity warrants in connection with convertible debt 679,577 679,577
Termination of shares issued during merger under FPA agreement 46,100 46,100
Net Income (Loss) (2,233,982) (2,233,982)
Balance at Mar. 31, 2025 $ 2,851 13,432,639 (12,796,781) 638,709
Balance (in Shares) at Mar. 31, 2025 28,510,632        
Balance at Dec. 31, 2024 $ 2,708 11,745,436 (10,562,799) 1,185,345
Balance (in Shares) at Dec. 31, 2024 27,080,915        
Net Income (Loss)           (6,327,213)
Balance at Jun. 30, 2025 $ 5,270 27,535,219 (16,890,012) 10,650,477
Balance (in Shares) at Jun. 30, 2025 52,703,070 500        
Balance at Mar. 31, 2025 $ 2,851 13,432,639 (12,796,781) 638,709
Balance (in Shares) at Mar. 31, 2025 28,510,632        
Share-based compensation $ 40 390,155 390,195
Share-based compensation (in shares) 400,000          
Termination of shares issued during merger under FPA agreement 94,472 94,472
Issuance of Preferred B stock for cash 500,000 500,000
Issuance of Preferred B stock for cash (in Shares) 500        
Issuance of common shares in connection with stock subscriptions $ 625 499,375 500,000
Issuance of common shares in connection with stock subscriptions (in shares) 6,250,000          
Issuance of common shares in connection with warrant exercises $ 1,096 9,862,213 9,863,309
Issuance of common shares in connection with warrant exercises (in shares) 10,958,681          
Issuance of common shares in connection with note conversions $ 658 1,225,455 1,226,113
Issuance of common shares in connection with note conversions (in shares) 6,583,757          
Deemed dividend - warrant modification 1,530,910 1,530,910
Net Income (Loss) (4,093,231) (4,093,231)
Balance at Jun. 30, 2025 $ 5,270 27,535,219 (16,890,012) 10,650,477
Balance (in Shares) at Jun. 30, 2025 52,703,070 500        
Balance at Dec. 31, 2025 $ 7,254 30,054,695 516,000 (21,114,473) 9,463,476
Balance (in Shares) at Dec. 31, 2025 72,536,722        
Share-based compensation employee $ 500 2,085,430 2,085,930
Share-based compensation employee (in Shares) 5,000,000          
Share-based compensation-non-employee $ 915 3,536,554 (516,000) 3,021,469
Share-based compensation-non-employee (in Shares) 9,150,000          
Termination of shares issued during merger under FPA agreement 412,329 412,329
Issuance of Preferred B stock for cash $ 5 47,939,995 47,940,000
Issuance of Preferred B stock for cash (in Shares)   47,940        
Issuance of common shares $ 3,455 2,399,104 2,402,559
Issuance of common shares (in Shares) 34,551,938          
Net Income (Loss) (13,857,203) (13,857,203)
Balance at Mar. 31, 2026 $ 12,124 $ 5 86,428,107 (34,971,676) 51,468,560
Balance (in Shares) at Mar. 31, 2026 121,238,660 47,940        
Balance at Dec. 31, 2025 $ 7,254 30,054,695 516,000 (21,114,473) 9,463,476
Balance (in Shares) at Dec. 31, 2025 72,536,722        
Net Income (Loss)           (17,542,263)
Balance at Jun. 30, 2026 $ 15,885 $ 5 96,544,698 (38,656,736) 57,903,852
Balance (in Shares) at Jun. 30, 2026 158,850,637 47,940        
Balance at Mar. 31, 2026 $ 12,124 $ 5 86,428,107 (34,971,676) 51,468,560
Balance (in Shares) at Mar. 31, 2026 121,238,660 47,940        
Share-based compensation employee $ 32 111,050 111,082
Share-based compensation employee (in Shares) 321,377        
Issuance of common shares in connection with warrant exercises 1,745 1,745
Issuance of common shares in connection with warrant exercises (in shares) 500        
Issuance of common shares in connection with June 2026 SPA, net of issuance cost $ 1,500 3,748,500 3,750,000
Issuance of common shares in connection with June 2026 SPA, net of issuance cost (in shares) 15,000,000        
Issuance of common shares in connection with Anortech share exchange $ 1,240 3,681,560 3,682,800
Issuance of common shares in connection with Anortech share exchange (in shares) 12,400,000        
Issuance of common stock under the At-the-Market facility $ 989 2,573,736 2,574,725
Issuance of common stock under the At-the-Market facility (in shares) 9,890,100        
Net Income (Loss) (3,685,060) (3,685,060)
Balance at Jun. 30, 2026 $ 15,885 $ 5 $ 96,544,698 $ (38,656,736) $ 57,903,852
Balance (in Shares) at Jun. 30, 2026 158,850,637 47,940